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SWAP-70-like adaptor of T cells (SLAT) is a guanine
nucleotide exchange factor for Rho GTPases that reg-
ulates the development of T helper 1 (Th1) and Th2 cell
inflammatory responses by controlling the Ca2+-
NFAT signaling pathway. However, the mechanism
used by SLAT to regulate these events is unknown.
Here, we report that the T cell receptor (TCR)-induced
translocation of SLAT to the immunological synapse
required Lck-mediated phosphorylation of two tyro-
sine residues located in an immunoreceptor tyro-
sine-based activation motif-like sequence but was
independent of the SLAT PH domain. This subcellular
relocalization was coupled to, and necessary for,
activation of the NFAT pathway. Furthermore, mem-
brane targeting of the SLAT Dbl-homology (catalytic)
domain was sufficient to trigger TCR-mediated
NFAT activation and Th1 and Th2 differentiation in
a Cdc42-dependent manner. Therefore, tyrosine-
phosphorylation-mediated relocalization of SLAT to
the site of antigen recognition is required for SLAT
to exert its pivotal role in NFAT-dependent CD4+
T cell differentiation.
INTRODUCTION
Engagement of the T cell receptor (TCR) by specific antigen-
major histocompatibility complex (MHC) complexes presented
by antigen-presenting cells (APCs) is central to the effective
induction of an antigen-specific T cell response. This cognate
antigen presentation, taking place at the T cell-APC interface
called the immunological synapse (IS), triggers biochemical
signaling cascades involving multiple cellular proteins, such as
protein tyrosine kinases, adapters, or cytoskeletal proteins,
and activates in turn a number of transcription factors, notably
NFAT, NF-kB, and AP-1. On a longer time scale, these pathways
result in changes of gene expression that ultimately lead to T cell
activation, proliferation, and differentiation.
Recently, we isolated a TCR-regulated protein called SWAP-
70-like adaptor of T cells (SLAT) (Tanaka et al., 2003) on the basis704 Immunity 29, 704–719, November 14, 2008 ª2008 Elsevier Inc.of its abundant expression in T helper 2 (Th2) cells and its homol-
ogy with SWAP-70, a B cell-enriched guanine nucleotide ex-
change factor (GEF) involved in B cell activation, immunoglobulin
class switching, and migration to lymphoid organs (Borggrefe
et al., 1998; Pearce et al., 2006; Shinohara et al., 2002). SLAT
(also called Def-6 or IBP) is abundant in central and peripheral
lymphoid tissues, with high amounts displayed in thymocytes
and in peripheral T cells (Becart et al., 2007; Gupta et al.,
2003b; Tanaka et al., 2003), and it translocates to the IS upon
antigen stimulation (Gupta et al., 2003a; Tanaka et al., 2003).
The human paralog of SLAT, termed IRF-4-binding protein
(IBP), was independently isolated by another group (Gupta
et al., 2003b) and later found to function as a TCR-regulated
GEF for the Rho GTPases Rac1 and Cdc42 (Gupta et al.,
2003a). In addition, SLAT cooperates with activated Rac1 to
induce a change in cell shape, most probably independently of
its GEF activity (Oka et al., 2007). Structurally, SLAT harbors,
beginning at its N terminus, a potential Ca2+-binding EF-hand
domain and an immunoreceptor tyrosine-based activation motif
(ITAM)-like sequence of unknown function, a PI(3,4,5)P3-binding
pleckstrin-homology (PH) domain (Gupta et al., 2003a; Oka et al.,
2007), and a Dbl-homology (DH) domain exhibiting GEF activity
(Gupta et al., 2003a).
Examination of SLAT-deficient mice on a mixed genetic
background revealed spontaneous development of systemic
lupus in aged female mice (Fanzo et al., 2006). Our recent anal-
ysis of SLAT-deficient mice on a homogenous C57BL/6 back-
ground revealed a role of SLAT in thymic DN1 cell expansion,
T cell activation, and Th1 and Th2 cell inflammatory responses
(Becart et al., 2007). The defect in Th1 and Th2 cell responses
was traced to defective Ca2+-NFAT signaling (Becart et al.,
2007). However, the molecular basis by which SLAT contributes
to NFAT activation is unknown. Here, we reported that SLAT
specifically activated NFAT, but not NF-kB or AP-1, upon
TCR triggering and that this NFAT activation correlated with,
and depended upon, its membrane and IS translocation. This
localization of SLAT required Lck-dependent phosphorylation
of two tyrosine residues in its ITAM-like sequence. Furthermore,
enforced targeting of the SLAT DH domain to the membrane
promoted TCR-induced NFAT activation in a Cdc42- and, to
a lesser extent, Rac1-dependent manner, and it restored
NFAT activation and Th1-Th2 cell differentiation in SLAT-defi-
cient CD4+ T cells.
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SLAT Enhances TCR-Induced NFAT Activity
and Is Recruited to the Membrane and IS
SLAT regulates Th1-Th2 cell differentiation by controlling NFAT
activation in CD4+ T cells (Becart et al., 2007). To further under-
stand the function of SLAT, we examined the effect of ectopic
SLAT expression on the TCR-mediated activation of NFAT,
NF-kB, and AP-1. SLAT-transfected Jurkat T cells showed a
dose-dependent increase in NFAT-reporter activity relative to
control transfectants (Figure 1A), which was abrogated by cyclo-
sporin A, an inhibitor of calcineurin (Figure 1B), confirming the
involvement of SLAT in modulating TCR-induced NFAT tran-
scriptional activity. In contrast, neither NF-kB nor AP-1 activity
was affected by SLAT (Figures 1C and 1D), and we confirmed
these results by demonstrating that the anti-CD3- and anti-
CD28-stimulated activation of these two transcription factors
was intact in primary SLAT-deficient CD4+ T cells (Figure S1
available online).
Next, we explored the subcellular localization of SLAT and the
mechanisms that regulate this distribution. Anti-CD3 and anti-
CD28 costimulation induced rapid SLAT translocation to the
membrane fraction; this translocation was still evident after
5 min (Figure 1E). Indicative of proper activation, stimulation
induced membrane translocation of PKC-q. CD3+CD28 costi-
mulation induced similar membrane translocation of SLAT in
murine peripheral T cells or thymocytes (Figure 1F). Furthermore,
we confirmed our earlier finding that TCR stimulation induces
translocation of SLAT to the IS (Figure 1G) (Gupta et al., 2003a;
Tanaka et al., 2003).
SLAT Localization andNFAT Activation Are Independent
of PI3-K and PIP3 Binding to the PH Domain
To gain more insight into the mechanism of SLAT-mediated
NFAT activation, we assessed the effect of various SLAT mu-
tants on NFAT activation (Figure 2A). A SLAT mutant lacking
the first 122 aminoterminal residues (DEF) stimulated NFAT
activity upon TCR stimulation to the same extent as wild-type
(WT) SLAT. Further deletion of residues 123–215 (PH+DH) abol-
ished NFAT activation (Figure 2B). Likewise, the isolated DH
domain also did not support NFAT activity (Figure 2B). These
results suggest a requirement for the region between the EF
and PH domains in linking TCR signals to NFAT activation. A
point mutation of Arg-236 (R236C), shown to be critical for bind-706 Immunity 29, 704–719, November 14, 2008 ª2008 Elsevier Inc.ing of the phosphoinositide 3-kinase (PI3-K) product PI(3,4,5)P3
(PIP3) to the SLAT PH domain (Gupta et al., 2003a), as well as
pretreatment with the PI3-K inhibitor LY294002, had no effect
on NFAT activation (Figures 2B and 2C). Thus, PIP3 binding to
the PH domain of SLAT and, hence, PI3-K activity are not
required for SLAT-mediated NFAT activation.
We then examined the subcellular localization of endogenous
SLAT or recombinant SLAT mutants. LY294002 or wortmannin
pretreatment had no effect on the TCR-induced translocation
of endogenous SLAT to the membrane in Jurkat or primary
CD4+ T cells (Figures 2D and 2E, respectively). The NFAT-acti-
vating DEF mutant was also recruited to the membrane after
anti-CD3 stimulation, whereas the nonactivating PH+DH and
DH proteins were not (Figure 2F). In contrast, the non-PIP3-bind-
ing R236C SLAT mutant underwent intact stimulus-induced
membrane translocation in transfected Jurkat T cells (Figure 2F)
as well as in stimulated SLAT-deficient CD4+ T cells, which were
infected with retrovirus expressing the R236C mutant (Fig-
ure 2G). Further analysis of the localization of the SLAT mutants
vis-a`-vis the IS in staphylococcal enterotoxin E (SEE)-stimulated
Jurkat T cells revealed that the R236C mutant was properly
localized to the IS (Figures 3A and 3B), and, moreover,
LY294002 pretreatment did not prevent the translocation of
WT SLAT in Jurkat T cells to the IS; conversely, the transfected
PH+DH and DH protein failed to undergo IS translocation (Fig-
ures 3A and 3B). To further evaluate the potential role of PIP3
binding to the PH domain in the context of an antigen-specific
primary T cell response, we crossed SLAT-deficient mice with
OT-II TCR-transgenic mice expressing an ovalbumin (Ova)-
specific TCR and evaluated the localization of retrovirally trans-
duced R236C SLAT mutant. Ova-peptide stimulation induced
translocation of the R236C SLAT mutant, but not the DHmutant,
to the IS (Figure 3C). The formation of an intact IS was confirmed
by our showing that CD4was also localized in the IS after antigen
stimulation (Figure 3C). Together, these results reveal a strict
correlation between TCR-mediated SLAT localization to the
membrane and IS and SLAT’s ability to activate NFAT; further-
more, they indicate that a mechanism distinct from PH-domain
binding to membrane-associated PIP3 is critical for the mem-
brane and IS recruitment of SLAT.
Phosphorylation of the ITAM-like Sequence of SLAT
The region between the EF and PH domains of SLAT contains an
ITAM-like sequence (residues 133–144). This sequence containsFigure 1. SLAT Enhances NFAT Activity and Translocates to the Membrane and IS
(A–D) Jurkat-TAg cells were cotransfected with empty pEF vector (10 mg) or with pEF vector encoding Xpress-taggedWTSLAT (1–10 mg), together with NFAT- (A),
NF-kB- (B), or AP-1- (C) luciferase reporters (10 mg) plus a b-Gal (5 mg) reporter gene. In (D), cells were also transfected with a CD28-encoding pSRa vector. Cells
were left unstimulated or stimulated with OKT3 (A–C) or OKT3 plus anti-CD28 (D) for the final 6 hr of a 24 hr culture. In (B), the cells were also treated with Cyclo-
sporin A (CsA; 10 mM) during the 6 hr stimulation period. Normalized luciferase activity was determined in duplicates, and graphs showmean ± SD. Expression of
transfected proteins was detected by anti-Xpress immunoblotting.
(E and F) Cytosolic (c) and membrane (m) fractions were prepared from Jurkat (JE6.1) T cells (E), peripheral T cells (F), or thymocytes (F) stimulated with anti-CD3
and anti-CD28 for the indicated times. Extracts were immunoblotted with the indicated antibodies (Abs). Numbers under the SLAT blot indicate the relative
expression of SLAT in the membrane fraction as determined by densitometry. SLAT expression in unstimulated membrane fraction was assigned a value of
1. Expression of p38 MAPK and Lck in the cytosolic or membrane fractions, respectively (E), confirmed proper separation of the different fractions. Vav1 served
as a normalization control.
(G) Jurkat-TAg cells were transfected with Xpress-SLAT. CMTMR-labeled Raji B cells were pulsed or not with SEE and mixed at a 1:1 ratio with the transfected
Jurkat cells. Conjugates were bound to poly-L-lysine-coated coverslips, fixed, and stained with anti-Xpress plus a secondary Alexa 488-coupled anti-mouse Ig.
Overlay of the green (Xpress-tagged SLAT) and red (CMTMR) images along with differential interference contrast (DIC) images are shown. Data shown are
representative of eight (A–D), five (G), and three (E and F) independent experiments.
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Structure-Function Analysis of SLATnegatively charged amino acids at conserved positions, the first
YxxL (or YxxI) motif, a spacer sequence of seven amino acids,
and a second Tyr-containing sequence, YxxK, in which a lysine
residue replaces the leucine or isoleucine typically found in
ITAM motifs (Figure 4A). A search of potential tyrosine-phos-
phorylation sites with the NetPhos2.0 algorithm revealed that
Tyr-133 and Tyr-144 display a high score. Therefore, we gener-
ated tyrosine-to-phenylalanine SLAT mutants (Figure 4B) and
examined their inducible phosphorylation. Pervanadate (PV)
stimulation of COS-7 cells resulted in SLAT phosphorylation
only when Lck was coexpressed (Figure 4C). In contrast, the
phosphorylation of the Y144F mutant and, to a lesser extent,
the Y133F mutant was drastically decreased (Figure 4D). Lck-
dependent phosphorylation of the Y133-144F double mutant
was completely abolished both in PV-stimulated COS-7 and in
TCR-stimulated Jurkat T cells (Figures 4C–4E). The importance
of Lck for SLAT phosphorylation was evidenced by the lack of
this TCR-stimulated phosphorylation in Lck-deficient JCam1.6
Jurkat cells (Figure 4F).
We confirmed the physiological relevance of these results by
infecting SLAT-deficient primary T cells with retroviruses
expressing WT or Y133-144F-mutated SLAT (Figure 4G). Phos-
phorylation of the Y133-144F mutant was decreased by 80%
relative to that of WT SLAT (Figure 4H). These results indicate
that SLAT undergoes Lck-dependent phosphorylation on Tyr-
144 and Tyr-133 upon TCR and CD28 stimulation.
Membrane and IS Recruitment of SLAT and NFAT
Activation Depend on Tyr-133+144 Phosphorylation
Wenext investigated theconsequencesofSLATphosphorylation
on SLAT’s membrane and IS translocation and NFAT activation.
A Src-family-kinase inhibitor, PP2, impaired the anti-CD3-stimu-
lated, SLAT-promoted NFAT activation in a dose-dependent
manner (Figure 5A). The Y133F mutant and, to a much larger
extent, the Y144F and Y133-144F mutants displayed reduced
ability to activate NFAT (Figure 5B). We also generated a ‘‘pseu-
doactive’’ mutant by replacing Tyr-133 and Tyr-144 with a nega-
tively charged aspartic-acid residue (Y133-144D) to mimic the
phosphorylated state. This mutant, in contrast to Y133-144F,
restored TCR-induced NFAT activation (Figure 5B).
In parallel, we analyzed the membrane and IS translocation of
tyrosine-mutated SLAT mutants. The Y133F mutation did not708 Immunity 29, 704–719, November 14, 2008 ª2008 Elsevier Inc.have a substantial effect on the membrane translocation of
SLAT (Figure 5D) and only mildly inhibited IS relocalization (Fig-
ure 5E), in agreement with its partial effect on the tyrosine phos-
phorylation of SLAT (Figure 4D) or NFAT activation (Figure 5B).
However, the Y144F and Y133-144F mutants were grossly
impaired in their membrane or IS translocation upon TCR
engagement (Figures 5D–5F). Interestingly, and in contrast to
the Y133-144F mutant, the phosphorylation-mimicking Y133-
144D mutant also translocated to the cell membrane in a stimu-
lus-dependent manner (Figure 5D). The importance of Lck-
dependent SLAT phosphorylation for its proper localization is
evident from the findings that CD3+CD28 costimulation failed
to induce membrane recruitment of endogenous SLAT in Lck-
deficient Jurkat cells (Figure 5C) and that PP2 blocked relocali-
zation of SLAT to the IS in SEE-stimulated WT Jurkat cells
(Figure 5E). We extended these findings to primary CD4+
T cells by demonstrating that, unlike WT SLAT, the Y133-144F
SLAT mutant did not localize to the IS in retrovirus-transduced,
Ova-peptide-stimulated SLAT-deficient OT-II CD4+ T cells
(Figure 5G). Thus, TCR+CD28-induced tyrosine phosphorylation
of Tyr-144 and, to a lesser extent, Tyr-133 regulates SLAT trans-
location to themembrane and IS and, consequently, is critical for
NFAT activation.
NFAT Activation Requires Membrane Recruitment
of SLAT DH Domain and Cdc42-Rac1 Activation
The DH domain of SLAT possesses TCR-stimulated GEF activity
for Rac1 and Cdc42 (Gupta et al., 2003a) (Figure S2), raising
a question as to whether the inability of SLAT-DH to activate
NFAT (Figure 2B) results from its failure to undergo membrane
and IS localization (Figures 2F and 3) or, rather, reflects GEF in-
dependence of SLAT-mediated NFAT activation. We generated
a construct (MyrDH) in which a membrane-localizing acylation
sequence, consisting of the seven NH2-terminal amino acids of
Lck (MGCVCSS), was fused to the DH domain of SLAT (Fig-
ure 6A). As a negative control, we also mutated the myristoyla-
tion site of Lck (Gly-2) to alanine (mMyr), a mutation that
abolishes Lck membrane localization (Yasuda et al., 2000). We
confirmed that MyrDH was constitutively localized at the mem-
brane and showed that it was recruited to IS in SEE-stimulated
Jurkat cells, whereas the unmodified DH domain or the mMyrDH
mutant were confined to the cytosol irrespective of TCRFigure 2. Mapping of SLAT Domains that Mediate NFAT Activation and Membrane Localization
(A) Schematic representation of Xpress-tagged SLAT mutants. The EF hand, ITAM-like, PH, and DH domains are shown.
(B) Jurkat-TAg cells were cotransfected with an empty vector or the indicated SLAT plasmids (10 mg) plus NFAT-luciferase and b-Gal reporter genes. Stimulation
and determination of relative luciferase units (RLU) were performed as in Figure 1A, and graphs showmean ± SD. SLAT expression was analyzed by anti-Xpress
immunoblotting (inset).
(C) NFAT-luciferase activity was determined in the presence or absence of LY294002 (10 mM). Expression of SLAT was analyzed after 6 hr stimulation (right, top).
Cells were stimulated or not for 5min with a CD3monoclonal antibody (mAb) in presence or absence of LY294002. Specificity of the PI3-K inhibitor was confirmed
by its inhibition of Akt phosphorylation and lack of effect on ERK1 and ERK2 phosphorylation (right, bottom). Graph shows mean ± SD.
(D and E) Jurkat cells (D) or CD4+ primary WT T cells (E) were pretreated or not for 45 min with wortmannin (D) or LY294002 (D and E) and stimulated or not with
anti-CD3 and anti-CD28 for 2 min. Cytosol and membrane fractions were prepared, resolved by SDS-PAGE, and immunoblotted with the indicated Abs. The
relative expression of SLAT in the membrane fraction (D) was determined as in Figure 1E.
(F) Jurkat-TAg cells transfected with the indicated SLAT plasmids were stimulated with anti-CD3 (2 min), and subcellular fractions were analyzed by immuno-
blotting. The relative expression of SLAT in the membrane fraction was determined as in Figure 1E. Data shown are representative of six (B and C) and three
(D, E, and F) independent experiments.
(G) SLAT-deficient CD4+ T cells preactivated with CD3+CD28 mAbs plus IL-2 were infected with WT SLAT or R236C-expressing retrovirus and cultured for
6 days. The GFP+ population was sorted and restimulated with CD3+CD28 mAbs for 2 min; then cytosol and membrane fractions were prepared, resolved
by SDS-PAGE, and immunoblotted with the indicated Abs.
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the retrovirus-transduced MyrDHmutant, but not the soluble DH
domain, localized to the IS in Ova-stimulated SLAT-deficient OT-
II CD4+ T cells (Figure 6D). This localization pattern was paral-
leled when the ability of these mutants to activate NFAT was an-
alyzed. Thus, in contrast to the cytosol-confined DH or mMyrDH
Figure 3. SLAT Recruitment to the IS
(A) Jurkat-TAg cells were transfected with Xpress-tagged SLAT plasmids as indicated. After 24 hr, the cells were pretreated or not with LY294002 for 1 hr, then
stimulated or not with SEE-pulsedCMTMR-labeled Raji B cells and analyzed as in Figure 1G.Overlay of the green (SLAT) and red (CMTMR) images alongwith DIC
images are shown.
(B) Quantitative analysis of the results shown in (A). SLAT localization in the IS was analyzed in 200–250 T-APC conjugates. SLAT recruitment to the IS was
classified in three categories: complete recruitment (represented by black bars), partial recruitment (represented by gray bars), or no recruitment (represented
by white bars). The graph represents the mean percentage of imaged cells scored in each group ± SD from three experiments.
(C) Preactivated SLAT-deficient OT-II CD4+ T cells were infected withWT SLAT-, DH-, or R236C-expressing retrovirus. Sorted GFP+ CD4+ T cells were incubated
with OVA323–339 peptide-pulsed (+OVA) or nonpulsed (OVA) DCs for 30 min. T-DC conjugates were then stained for CD4 (blue) and SLAT (red) expression.
Corresponding DIC images are also shown. CD4 staining serves as a control of proper peptide-specific IS formation. Asterisks indicate T cells.Immunity 29, 704–719, November 14, 2008 ª2008 Elsevier Inc. 709
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extent as did WT SLAT (Figure 6E).
GEF-mediated activation of Rho GTPases induces actin-cyto-
skeleton reorganization, which is required for TCR-induced T cell
activation. Therefore, we determined whether SLAT-induced
NFAT activation depends on actin-cytoskeleton reorganization
by analyzing the effect of Latrunculin B, an inhibitor of actin
polymerization. This drug inhibited the TCR-stimulated NFAT
activation in empty-vector-transfected cells and, moreover,
also inhibited TCR-dependent NFAT activation mediated by
WT SLAT or by MyrDH by 75% and 95%, respectively (Fig-
ure 6F, left), suggesting that actin-cytoskeleton reorganization
is required for SLAT-mediated NFAT activation.
To further investigate the role of SLAT GEF activity in NFAT
activation, we examined the effect of dominant-negative RhoA
(RhoAN19), Rac1 (Rac1N17), or Cdc42 (Cdc42N17) mutants on
SLAT-mediated NFAT activation. RhoAN19 had no effect on
NFAT activation (data not shown), whereas Cdc42N17 and, to
a lesser extent, Rac1N17 inhibited the SLAT- andMyrDH-induced
NFAT activation (Rac1N17: 25%–40% inhibition; Cdc42N17:
75%–95% inhibition) (Figure 6G). Given this result, we also
used the reverse approach by determining whether constitu-
tively active Cdc42 (V12Cdc42; Cdc42CA) can restore the
impaired NFAT-Ca2+ signaling in SLAT-deficient primary CD4+
T cells. For this purpose, we used a protein-transduction ap-
proach, in which the cells were transduced with recombinant
Cdc42CA fused to a Tat-derived transduction peptide (Tskvita-
ria-Fuller et al., 2007). This recombinant fusion protein is trans-
duced into primary T cells with high efficiency, and it was previ-
ously found to be functional (Tskvitaria-Fuller et al., 2007).
Indeed, SLAT-deficient CD4+ T cells transduced with the Tat-
Cdc42CA protein regained their ability to undergo NFAT nuclear
translocation (Figure 6H) and Ca2+ mobilization (Figure 6I) in re-
sponse to anti-CD3 and anti-CD28 costimulation. Furthermore,
Th1 cell differentiation measured by IFN-g expression, which is
normally impaired in SLAT-deficient CD4+ T cells (reflecting the
critical role of NFAT in T cell differentiation) (Becart et al., 2007),
was restored when SLAT-deficient primary CD4+ T cells were
transduced with retrovirus expressing a Cdc42CA mutant (Fig-
ure 6J). These data establish a causal link between the GEF ac-
tivity of SLAT and the resulting activation of Cdc42 on one hand,
and its critical function in promoting activation of the Ca2+-NFAT
signaling pathway and, consequently, Th cell differentiation, on
the other.
Restoration of Th Differentiation and NFAT Activation
in SLAT-Deficient Primary T Cells
To determine the physiological relevance of our findings, we in-
fected SLAT-deficient CD4+ T cells with bicistronic GFP retrovi-
ruses expressing WT (full-length) SLAT or various SLAT mutants
and analyzed NFAT activation and Th1-Th2 cell differentiation.
As controls, both NFATc1 and NFATc2 effectively translocated
to the nucleus in WT T cells and in WT SLAT-reconstituted
SLAT-deficient T cells (but not in empty-vector-transduced
SLAT-deficient T cells) upon TCR+CD28 ligation (Figure 7A).
Strikingly, however, reconstitution with a retroviral vector
expressing the membrane-targeted (but not the cytosolic) DH
domain fully rescued nuclear NFAT translocation (Figure 7A).
Similarly, the R236C SLAT mutant also restored NFAT nuclear710 Immunity 29, 704–719, November 14, 2008 ª2008 Elsevier Inc.translocation; however, the Y133-144F mutant did not rescue
NFAT activation (Figure 7A), consistent with our previous results
(Figures 2 and 5).
Because impaired activation of both NFATc1 and NFATc2
accounts for the defective Th1 and Th2 cell responses in
SLAT-deficient mice (Becart et al., 2007), we further investigated
the ability of the same SLATmutants to rescue Th1 (Figure 7B) or
Th2 cell differentiation (Figure S3) of SLAT-deficient T cells. As
shown before (Becart et al., 2007), SLAT-deficient CD4+ T cells
transduced with the empty vector displayed a 50% reduction
in both IFN-g and IL-4 production in comparison to that of their
WT counterparts, and both GFP and GFP+ populations dis-
played this defect (Figure 7B and Figure S3). In contrast, infec-
tion of these cells with WT SLAT-expressing retrovirus restored
Th1 and Th2 cell differentiation to normal, WT T cell levels
(Figure 7B and Figure S3). As an internal control, the GFP
(nontransduced) populations of SLAT-deficient CD4+ T cells still
displayed a defect in IL-4 or IFN-g expression. In full correlation
with the effect of the SLAT mutants on NFAT nuclear transloca-
tion (Figure 7A), the MyrDH and R236C SLAT mutants, but not
DH or Y133-144F, fully rescued the Th1 (Figure 7B) and Th2
(Figure S3) cell-differentiation defect.
Lastly, we confirmed the restoration of Th1 cell differentiation
of SLAT-deficient T cells in the context of an in vivo antigen-
specific response by using an adoptive-transfer system (Fig-
ure 7C). As a positive control, 24% of adoptively transferred
CD4+ WT OT-II T cells were IFN-g+, whereas, in contrast, only
5% of the transferred SLAT-deficient T cells reconstituted with
empty pMIG expressed IFN-g, confirming the defective Th1 cell
differentiation of SLAT-deficient CD4+ T cells (Figure 7C). How-
ever, retroviral reconstitution with full-length SLAT, membrane-
targeted MyrDH, or R236C, but not Y133-144F, resulted in
similar proportions (15%–20%) of IFN-g+ T cells, approaching
the level of IFN-g+ cells in the positive control group (Figure 7C).
These results indicate that membrane targeting of the isolated
SLAT DH domain is necessary and sufficient for proper TCR-
induced NFAT activation and CD4+ T cell differentiation.
DISCUSSION
NFAT is a major mediator of productive T cell activation, and its
activation is required for production of various cytokines, includ-
ing IL-2 (Masudaet al., 1998), IL-4 (Chuvpilo et al., 1993), and IFN-
g (Campbell et al., 1996). Therefore, analysis of the regulation of
SLAT function was of major interest because we found SLAT to
be a key component of theCa2+-NFAT pathway in T lymphocytes
(Becart et al., 2007). In addition, SLAT plays a role in actin poly-
merization through its ability to activate the small Rho GTPases
Rac1 and Cdc42 (Fanzo et al., 2006; Gupta et al., 2003a).
The current study establishes SLAT as a key protein linking ac-
tin-cytoskeleton reorganization and Cdc42-Rac1 activation to
Ca2+-NFAT signaling and, consequently, to Th1 and Th2 cell dif-
ferentiation. SLAT translocated to the membrane and IS and po-
tently activated NFAT in a TCR-dependent manner, but it was
dispensable for AP-1 and NF-kB activation, in agreement with
the phenotype of SLAT-deficient primary T cells (Becart et al.,
2007). Consistent with the findings that IS assembly and translo-
cation of signaling molecules to the membrane and IS greatly
influence T cell activation (Grakoui et al., 1999), we observed
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SLAT membrane and IS recruitment and SLAT’s ability to acti-
vate NFAT. Both events required the Lck-dependent phosphor-
ylation of Tyr-133 and Tyr-144. However, the combined PH-DH
domains were not sufficient, and PI3-K-dependent binding of
the PH domain to PIP3 was not even required. Furthermore,
enforced membrane targeting of the isolated DH domain was
sufficient to enhance TCR-stimulated NFAT activation in a
Cdc42-Rac1-dependent manner, controlling in turn Th1 and
Th2 cell differentiation. The corroboration of these findings in
primary T cells establishes the physiological relevance of these
findings.
The lack of any apparent regulatory role for SLAT PH-domain
binding tomembrane-associated PIP3, aswell as the importance
of Tyr-144 in these events, are at odds with another study (Gupta
et al., 2003a). This studydemonstrated that the IS translocation of
SLAT depended onPI3-K and, furthermore, that SLATGEF activ-
ity was stimulated by Lck-mediated tyrosine phosphorylation of
another tyrosine residue, Tyr-210 (Gupta et al., 2003a).We found,
however, that mutation of Tyr-210 did not alter the Lck-depen-
dent phosphorylation of SLAT (Figure S4), consistent with the
low score obtained for Tyr-210 with the NetPhos2.0 algorithm.
The reasons for these discrepancies are unclear. However, our
results were obtained by several independent and complemen-
tary approaches, including retroviral transduction of SLAT-
deficient primary T cells, thereby establishing the robustness of
our findings. Furthermore, the previous finding of Lck-mediated
phosphorylation of SLAT on Tyr-210 was based on analysis of
Lck-overexpressing non-T (293T) cells (Gupta et al., 2003a).
Interestingly, phosphorylation of Tyr-133 and Tyr-144 was re-
quired, but not sufficient, for inducing NFAT activation because
a SLAT mutant mimicking phosphorylation of these residues
(Y133-144D) still needed TCR stimulation in order to activate
NFAT and translocate to the cell membrane, suggesting that
SLAT membrane and IS translocation is required but not suffi-
cient. Similarly, enforced membrane targeting of the isolated
DH domain with the MyrDH mutant also was not sufficient to
activate NFAT and required TCR stimulation. Furthermore, the
MyrDH- (or WT SLAT-) induced NFAT activation was dependent
on functional Cdc42 (and Rac1?), as indicated by the ability of
a DN Cdc42 mutant to block SLAT-dependent NFAT activation
and, conversely, the restoration of NFAT nuclear translocation,
Ca2+ mobilization, and Th1 cell differentiation in SLAT-deficient
CD4+ T cells by transduced constitutively active Cdc42. These
findings make a strong case for a causal role of the GEF activity712 Immunity 29, 704–719, November 14, 2008 ª2008 Elsevier Inc.of SLAT in inducing its Ca2+- and Th-differentiation-promoting
activities and, thus, provide a mechanistic basis for our previous
findings that SLAT-deficient T cells display impaired Ca2+-NFAT
signaling and Th cell differentiation (Becart et al., 2007). So far,
we (and others) have not identified DH domain residue(s) essen-
tial for the GEF activity of SLAT (or SWAP-70), mutation of which
would be required to directly establish the importance of theGEF
activity of SLAT for Ca2+ signaling and Th cell differentiation.
However, it is important to note that the DH domain of SLAT
lacks sufficient primary amino acid sequence homology with
‘‘conventional’’ DH domains or even with the DH domain of
its close relative, SWAP-70, thereby making this task the goal
of future analysis.
Together, these findings indicate that additional TCR-induced
signals, beyond the mere membrane and IS translocation of
SLAT, are required for its proper function. One likely regulatory
model is that the Lck-mediated phosphorylation of SLAT creates
a binding site or sites for an undefined critical TCR-regulated
adaptor protein and/or induces a conformational change in
SLAT (that is not fully mimicked by the Y133-144D mutant). As
a result of such a modification, SLAT is recruited to the IS, where
it can access and activate Rho GTPases. In any case, the ability
of MyrDH SLAT to fully activate NFAT and to reconstitute Th1
and Th2 cell differentiation in SLAT-deficient primary T cells
clearly demonstrates that, first, mislocalization of the SLAT DH
domain in the cytosol upon TCR engagement underlies its inabil-
ity to activate NFAT. Second, it substantiates the conclusion that
membrane and IS association of SLAT is a prerequisite for NFAT
activation.
SLAT-deficient T cells display impaired IS formation and
defective actin polymerization (Fanzo et al., 2006), most likely
due to impaired Cdc42-Rac1 activation, along with a defect in
Ca2+-NFAT signaling (Becart et al., 2007). As mentioned above,
the dependence of Ca2+-NFAT activation on Cdc42 (and, to
a lesser extent, Rac1) activity implicates SLAT as a key actin-cy-
toskeleton regulator linking activation of Rho GTPases to NFAT
activity, and it is consistent with Cdc42 andRac being substrates
for the GEF activity of SLAT (Gupta et al., 2003a). In this context,
antigen-receptor-stimulated NFAT activation was previously
found to require Rac1 activity (Turner et al., 1998). The impor-
tance of Rho GTPase-mediated actin-cytoskeleton reorganiza-
tion in assembly of the IS and in controlling early events preced-
ing gene transcription (such as migration, integrin activation, or
conjugate formation) is well established (Cannon and Burkhardt,
2002; Tybulewicz, 2005; Wang et al., 2003). However, theFigure 4. Lck-Dependent Phosphorylation of Tyr-133 and Tyr-144 in SLAT
(A) Comparison of the ITAM-like sequence of SLAT with the consensus ITAM. Gray boxes indicate conserved amino acids.
(B) Schematic representation of Tyr-mutated SLAT plasmids.
(C–E) COS-7 (C and D) or Jurkat-TAg (E) cells were transfected with the indicated plasmids and stimulated for 2 min with PV (C and D) or anti-CD3 (E). SLAT
immunoprecipitates (top two panels) or cell lysates (bottom two panels) were analyzed by immunoblotting. Numbers under the p-Tyr blot indicate the relative
phosphorylation of SLAT as determined by densitometry.
(F) WT (JE6.1) and Lck-deficient (JCaM1.6) Jurkat cells were stimulatedwith anti-CD3 for the indicated periods of time. SLAT immunoprecipitates (top two panels)
or cell lysates (bottom two panels) were analyzed as in (C)–(E).
(G) Schematic diagram of retroviral pMIG-SLAT constructs.
(H) Primary SLAT-deficient T cells preactivated with anti-CD3 and anti-CD28 plus IL-2 were infected with WT SLAT or Y133-144F-expressing retrovirus and
cultured for 6 days. GFP+ and GFP populations were sorted and restimulated with anti-CD3 and anti-CD28 for 5 min, and SLAT immunoprecipitates were
analyzed by immunoblotting with the indicated Abs (top two panels). Cell lysates were blotted with anti-SLAT (bottom panel). The GFP population served as
a negative control. Numbers under the p-Tyr blot indicate the relative phosphorylation of SLAT proteins. The data shown are representative of three independent
experiments.
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are far less clear. The finding that cytochalasin D treatment im-
pairs TCR-stimulated NFAT, but not NF-kB or AP-1, activation
(Nolz et al., 2007) suggests that the actin cytoskeleton does
not globally regulate all TCR-stimulated signaling pathways. It
is intriguing that the Slatmutation results in a similar phenotype,
i.e., impaired NFAT activation in the face of intact NF-kB or AP-1
activation.
Several Cdc42-Rac1 effectors can selectively regulate Ca2+-
NFAT signaling. For example, theWiskott-Aldrich syndrome pro-
tein (WASP), a Cdc42 effector, plays a role in actin-cytoskeleton
rearrangements as well as in NFAT activation via its association
with WIP (Dong et al., 2007; Huang et al., 2005; Silvin et al.,
2001). Similarly, the WAVE2 complex regulates actin-cytoskele-
ton reorganization but is also required for NFAT (but not NF-kB or
AP-1) activation, reflecting its essential role in calcium-release-
activated calcium (CRAC)-channel-mediated Ca2+ entry (Nolz
et al., 2006). Finally, Pak1 kinase, a common Rac1 and Cdc42
effector, is involved in NFAT activation via its Lck-mediated
phosphorylation and resulting association with the adaptor Nck
(Yablonski et al., 1998). Therefore, further studies will be required
in order to identify downstream effectors involved in Cdc42-
Rac1-dependent, SLAT-mediated NFAT activation and deter-
mine whether they are linked to any of the regulators of the actin
cytoskeleton and Ca2+ signaling discussed above. In this regard,
we found that MyrDH-mediated NFAT activation was totally
abrogated by an ERK, but not a p38, kinase inhibitor (Figure S5).
This data is consistent with accumulating evidence showing that
Rho GTPases regulate gene transcription through diverse distal
effector elements of the TCR signaling pathway, including extra-
cellular signal-regulated kinase (ERK) (Frost et al., 1997; Jiang
et al., 2000; Yablonski et al., 1998), whose activation is also
decreased in SLAT-deficient T cells (Becart et al., 2007). Notably,
Yablonski et al. (Yablonski et al., 1998) demonstrated that Rac
and Cdc42 could influence NFAT by activating ERK through its
target Pak1 in T cells. Cdc42 has also been recently shown to
specifically modulate ERK activation (Marques et al., 2008),
and other studies provide evidence of a functional coupling of
NFAT transcriptional activity and Ras-MEK-ERK activation
(Sanna et al., 2005; Tsukamoto et al., 2004; Villalba et al.,
2000; Yang et al., 2005).
Our finding that enforced membrane targeting of the SLAT DH
domain is sufficient to restore NFAT activation and Th1 or Th2714 Immunity 29, 704–719, November 14, 2008 ª2008 Elsevier Inc.cell differentiation in SLAT-deficient CD4+ T cells suggests that
the failure to stimulate sufficient Cdc42 and/or Rac1 activity ac-
counts for the NFAT-dependent Th1-Th2 cell defects of SLAT-
deficient T cells. This notion is further reinforced by our findings
that the downstream defects observed in SLAT-deficient T cells,
i.e., the impaired NFAT activation and Th cell differentiation, can
all be reversed by expression of a constitutively active Cdc42
mutant. This causality between activation of Rho-family
GTPases and Th cell differentiation is consistent with reports
showing that (1) Rac2 activates Th1 cell-specific signaling (Li
et al., 2000), and (2) CD4+ T cells fromWiskott-Aldrich syndrome
patients (mutated inWAS gene encoding WASP) display defec-
tive Th1 cell response due to impaired NFATc2 activation (Trifari
et al., 2006). Importantly, however, our findings go one step fur-
ther by implicating SLAT as a critical regulator of not only Th1 cell
responses, but also Th2 cell responses and, furthermore, link this
regulatory function in a causal manner to the small GTPase-stim-
ulating GEF activity of SLAT and, hence, to actin-cytoskeleton
reorganization.
In summary, our data provide evidence that TCR+CD28 stimu-
lation induce Lck-mediated membrane localization of SLAT.
Thereafter, TCR-specific signals facilitate the triggering of SLAT
GEF activity toward Cdc42 and Rac1, leading to NFAT activation
and Th1 and Th2 cell differentiation. Further work aiming at eluci-
dating SLAT-interacting partners may thus shed light on the
poorly understood events that coordinate and link actin-cytoske-
letonreorganization to Ca2+ signaling and gene transcription in
T cells. Moreover, strategies aimed at inhibiting the translocation
of SLAT to the IS or,more directly, its GEF activitymay provide an
efficientmeansof blocking themachineryofCa2+-NFATsignaling
in T cells for the treatment of NFAT-dependent autoimmune and
inflammatory diseases. In that regard, SLATmay turn out to be an
attractive drug target with potentially similar importance to that of
the recently discovered T cell CRAC channel, Orai1 (Feske et al.,
2006; Vig et al., 2006; Yeromin et al., 2006), and the Ca2+ sensor,
Stim1 (Roos et al., 2005; Zhang et al., 2005).
EXPERIMENTAL PROCEDURES
Antibodies and Reagents
SLAT-specific antisera were prepared as described (Tanaka et al., 2003).
Monoclonal antibodies (mAbs) specific for human CD3 (OKT3) and pTyr
(4G10) were affinity purified from hybridoma-culture supernatants asFigure 5. Role of Tyr-133 and Tyr-144 Phosphorylation in SLAT Membrane and IS Recruitment and NFAT Activation
(A) Luciferase-reporter activity in lysates of Jurkat-TAg cells cotransfected with empty or WT SLAT-expressing vector, along with an NFAT-luciferase reporter
gene and a b-Gal reporter. Eighteen hr after transfection, the cells were incubated with PP2 and left unstimulated or were stimulated for 6 hr with anti-CD3.
The graph showsmean of RLU ±SD. Inset, upper panels: Immunoblot analysis of lysates from transfected, PP2-treated and -stimulated cells. Inset, lower panels:
Cells were pretreated with 1 or 10 mMPP2 for 45min and stimulated with anti-CD3 for 5min. Lysates were immunoblotted with the indicated Abs for confirmation
of the effectiveness and specificity of PP2 pretreatment.
(B) Luciferase-reporter activity in lysates of Jurkat-TAg cells transfected with the indicated SLAT mutants plus NFAT-luciferase and b-Gal reporter genes. The
graph shows mean of RLU ± SD. Expression of SLAT proteins was analyzed by anti-Xpress immunoblotting (inset).
(C) Cytosolic (c) and membrane (m) fractions from WT (JE6.1) and Lck-deficient (JCaM1.6) Jurkat cells stimulated with anti-CD3 and anti-CD28 for 2 min were
immunoblotted as indicated. Relative SLAT expression in the membrane fraction was determined as in Figure 1E.
(D) Jurkat-TAg cells transfected with the indicated SLAT plasmids were stimulated with anti-CD3. Subcellular fractions were analyzed by immunoblotting. The
relative expression level of SLAT proteins in the membrane fraction was determined as in Figure 1E.
(E) Jurkat-TAg cells transfected with the indicated SLAT plasmids were pretreated or not with PP2 (10 mM) for 45 min, then stimulated with CMTMR-labeled
SEE-pulsed (or control) Raji B cells (red). SLAT localization (green) was analyzed as in Figure 1G.
(F) Quantitative analysis of SLAT localization in the IS was performed as in Figure 3B.
(G) Preactivated SLAT-deficient OT-II CD4+ T cells were infected with WT SLAT- or Y133-144F-expressing retrovirus. Sorted GFP+ CD4+ T cells were stimulated
and analyzed as in Figure 3C. Asterisks indicate T cells. The data shown are representative of four (A and B), three (C–F), and two (G) independent experiments.
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Structure-Function Analysis of SLATdescribed (Liu et al., 1997). The human CD28mAb and anti-mouse CD4 (RM4-
5) were from PharMingen. The XpressmAbwas from Invitrogen. Lck, ERK2 (D-
2) -c-Myc (9E10; for immunoblotting), NFATc1 (7A6), NFATc2 (4G6-G5),
Cdc42 (P1), and lamin B Abs were from Santa Cruz Biotechnology. Rat a-tu-
bulin (YL1/2) Ab was purchased from Serotec, and PKC-q Ab was obtained
from Transduction Laboratories. Phospho-Tyr319 ZAP-70, phospho-Thr202
and Tyr204 ERK1+2, Akt, and p38 polyclonal Abs and phospho-Ser473 Akt
and ZAP-70 (99F2) rabbit mAbs were obtained from Cell Signaling Technol-
ogy. Mouse CD33 (145-2C11) and CD28 (37.51) mAbs were purchased from
Biolegend. Vav1 Ab was from Upstate Biotechnologies, and c-Myc mAb
used for immunofluorescence was obtained from Roche Applied Science.
The IkB-a Ab was from Santa Cruz Biotechnology. SEE was from Toxin Tech-
nology. The cell tracker orange (CMTMR), Alexa-488-conjugated anti-mouse
Ig Ab, Alexa-555-conjugated anti-rabbit Ig Ab, and Alexa-647-conjugated
anti-rat Ig Ab were obtained from Molecular Probes. The Src inhibitor (PP2),
latrunculin B, LY294002, and wortmannin were obtained from Calbiochem.
The recombinant Tat-Cdc42CA fusion protein was a kind gift from C. Wu¨lfing
(Tskvitaria-Fuller et al., 2007).
Plasmids
Xpress-tagged WT SLAT (pEF-SLAT-Xpress) plasmid was generated by sub-
cloning of the murine SLAT cDNA into the EcoRI sites of the pEF4-His C ex-
pression vector (Clontech) encoding an in-frame Xpress tag epitope upstream
of the insert. The pEF-SLAT-Myc expression plasmid was constructed by
cloning of the SLAT cDNA, fused in frame with a c-Myc epitope-coding se-
quence at its 30 terminus, into the EcoRI and NotI sites of the pEF-Myc-His
A vector. Various Xpress-tagged deletion mutants of SLAT were constructed
by PCR amplification from full-length SLAT vectors with the following primers:
SLAT-DEF (D1–90) forward primer (FP1): 50-GGTACCGGATGAGTTGTGCTG
GACCCT-30; reverse primer (RP1): 50-GCGGCCGCCTAATTCCCTGGTGCTG
GATCC-30. SLAT-PH+DH (D1–216) FP2: 50GGTACCGGTCCTGAAGCAGGGC
TATCT-30; reverse primer RP1. SLAT-DH (D1–312) FP3: 50-GAATTCCTGCA
GGCGGAGGGGAAGAC-30; reverse primer RP1. PCR products were inserted
into KpnI-EcoRI (for SLAT-DEF and SLAT-PH+DH) or EcoRI-NotI (for SLAT-
DH) sites of pEF4-His C vector and sequenced to confirm correct nucleotide
sequence. Underlining indicates unique restriction sites used for subcloning.
The pEF-MyrDH vector was generated by amplification of the SLAT DH do-
main with a 50 primer encoding the membrane-localizing acylation sequence
of Lck. The Y133F and/or Y144F or D, R236C, and mutated MyrDH (mMyrDH)
point mutations were introduced by use of a site-directed mutagenesis kit716 Immunity 29, 704–719, November 14, 2008 ª2008 Elsevier Inc.(Stratagene). Presence of single mutations was confirmed by DNA sequenc-
ing. Dominant-negative forms of Rac1 (Rac1N17) and Cdc42 (Cdc42N17) were
expressed in pEF or pCAN vectors, respectively.
Mice, Cell Culture, Purification, and Transfection
Mice were maintained under specific pathogen-free conditions in accordance
with guidelines of the Association for Assessment and Accreditation of Labo-
ratory Animal Care International. SLAT-deficient mice on a C57BL/6 back-
ground have been previously described (Becart et al., 2007). SLAT-deficient
OT-II TCR-transgenic mice were generated by intercrossing OT-II TCR-trans-
genic mice and SLAT-deficient mice (both on a C57BL/6 background), and
their T cells were used as a source of Vb5-Va2 CD4+ T cells specific for amino
acid residues 323–339 of Ova (OVA323–339). Six- to 10 week-old mice were
used in all experiments. After erythrocyte lysis, lymph node and spleen
T cells were enriched to >90% purity on mouse T cell-enrichment columns
(R&D Systems). CD4+ T cells were isolated by positive selection with CD4
(L3T4) mAb-coated microbeads (MACS). T cells were cultured in RPMI-1640
medium (Life Technologies) supplemented with 10% heat-inactivated fetal
bovine serum (FBS), 2 mM glutamine, 1 mM sodium pyruvate, 10 mM HEPES,
1mMMEMnonessential amino acid solution, and 100U/ml each of penicillin G
and streptomycin (Life Technologies). Short stimulation of murine T cells was
performed as described (Becart et al., 2007).
Simian virus 40 large T antigen-transfected human leukemic Jurkat T cells
(Jurkat-TAg), WT Jurkat cells (clone JE6.1), Lck-deficient (JCaM1.6) Jurkat
T cells, and Raji B cells were obtained from ATCC and grown in the same
RPMI-1640 medium. Jurkat-TAg cells in logarithmic growth phase were trans-
fected with plasmid DNAs by electroporation (Villalba et al., 2001). The cells
were washed with serum-free RPMI-1640 medium, serum starved, incubated
with the human CD3 and CD28 mAbs on ice, and stimulated at 37C for the in-
dicated times by crosslinking with a secondary goat anti-mouse IgG (Pierce),
as described (Charvet et al., 2005). Short stimulation of Jurkat-TAg cells (sub-
cellular fractionation and immunoprecipitation experiments) was performed
with crosslinked OKT3 mAb for the indicated times at 37C. COS-7 cells
were grown in DMEM medium plus 10% FBS and transfected with the Tran-
sIT-LT1 transfection reagent (Mirus). After 24 hr, transfected cells were har-
vested for stimulation with 1% (w/v) PV and cell-extract preparation.
Immunofluorescence Microscopy
Conjugation of transfected Jurkat-TAg cells and Raji B cells, staining, and
preparation of the samples for microscopy were performed as describedFigure 6. Membrane Targeting of the SLAT DH Domain Is Sufficient to Induce Cdc42- and Rac1-Dependent NFAT Activation
(A) Schematic representation of retroviral Myc-tagged SLAT constructs. The Lck residues that are modified by myristoylation (Myr) or palmitoylation (Palm) are
indicated.
(B) Jurkat-TAg cells were transfected with the indicated Myc-tagged vectors, and cytosolic and membrane fractions were analyzed by immunoblotting.
(C) Jurkat-TAg cells were transfected with the indicated Myc-tagged SLAT plasmids and stimulated with CMTMR-labeled SEE-pulsed (or control) Raji B cells
(red). Overlays of the green (SLAT) and red (CMTMR, B cell) images are shown. The data shown are representative of four independent experiments.
(D) Preactivated SLAT-deficient OT-II CD4+ T cells were infected with DH- or MyrDH-expressing retrovirus. Sorted GFP+ CD4+ T cells were stimulated and
analyzed as in Figure 3C. Asterisks indicate T cells.
(E and F) Jurkat-TAg cells were transfected with Myc-tagged SLAT plasmids plus NFAT-luciferase and b-Gal reporter genes. In (F), transfected cells were pre-
treated or not with latrunculin B (0.25 mM) for 1 hr prior to 6 hr of anti-CD3 stimulation. Expression of SLAT proteins was analyzed by anti-Myc immunoblotting (top
right panel in [F]). Efficiency of latrunculin B treatment was assessed by phalloidin staining of Jurkat-TAg cells (bottom right panel in [F]). Latrunculin B inhibited
actin polymerization but not the expression of the SLAT or MyrDH, nor did it alter the constitutive membrane targeting of the MyrDH protein (right panel in [F]).
Graphs show mean of luciferase activity ± SD and are representative of five independent experiments.
(G) Jurkat-TAg cells were transfected with SLAT plasmids along with Rac1N17 or Cdc42N17 plus NFAT-luciferase and b-Gal reporter genes. Normalized luciferase
activity was determined as in Figure 1A, and the graph shows mean ± SD representative of four independent experiments.
(H) WT and SLAT-deficient (knockout [KO]) CD4+ T cells were activated with CD3+CD28 mAbs plus IL-2 for 48 hr, rested overnight, transduced or not with 1 mM
recombinant Tat-Cdc42CA protein for 30min, and restimulated with CD3+CD28mAbs for 2 hr. Cytoplasmic (C) and nuclear (N) fractionswere immunoblotted with
NFATc1 or NFATc2 Abs. Fractions were also immunoblotted with a-tubulin and lamin B Abs to confirm purity of the fractions, respectively. Whole-cell lysates
were also immunoblotted with Cdc42, -SLAT, and -Vav1 Abs for assessing the efficiency of Tat-mediated transduction of Cdc42CA ([H], bottom).
(I) [Ca2+]i was measured by flow cytometry in indo1-loaded CD4
+ T cells fromWT and SLAT-deficient (KO) mice. Tat-Cdc42CA transduction was performed as in
(H), and TCR+CD28 costimulation was performed with a crosslinking goat anti-hamster (gah) Ig Ab, followed by the addition of thapsigargin (Thapsi). Data are
expressed as a histogram displaying FL5/FL4 ratio versus time (s).
(J) Preactivated WT and SLAT-deficient (KO) primary CD4+ T cells were transduced with retroviral vectors expressing either GFP alone (Empty) or GFP plus pMX
Cdc42Q61L (Cdc42CA) and differentiated under Th1 cell conditions. Sorted GFP+ populations were restimulated with anti-CD3 and anti-CD28 for 24 hr, and IFN-g
in culture supernatants was quantified by an ELISA. Graphs show mean of IFN-g production ± SD. Retroviral gene transduction was used in this experiment
(instead of Tat-mediated protein transduction) because this approach allows for stable, long-term gene expression (in contrast to Tat-Cdc42CA, which is stable
for only 4 hr).
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permeabilized, and stained with TRITC-conjugated phalloidin (Sigma-Aldrich).
For antigen-specific stimulation, retrovirally transduced CD4+ T cells from
SLAT-deficient or WT OT-II TCR-transgenic mice were incubated with
10 mg/ml OVA323–339 peptide-pulsed or nonpulsed dendritic cells (DCs). Cells
were briefly centrifuged to promote conjugate formation and incubated at
37C for 30 min in serum-free medium on poly-L-lysine-coated slides, then
fixed with 4% paraformaldehyde, permeabilized with 0.1% Triton X-100 in
PBS, and stained with mouse CD4 (RM4-5; PharMingen) and SLAT Ab. Goat
anti-rat and anti-rabbit IgG secondary antibodies conjugated to Alexa Fluor
647 or Alexa Fluor 555 (Molecular Probes), respectively, were used to
visualize primary antibodies. Immunofluorescence images were recorded by
a Marianas digital fluorescence-microscopy system (Intelligent Imaging Inno-
vations) as described (Charvet et al., 2005). A minimum of 100 randomly
Figure 7. Restoration of NFAT Activation and Th1-Th2 Cell Differentiation by Membrane-Targeted SLAT DH Domain
(A) WT and SLAT-deficient CD4+ T cells were activated with anti-CD3 plus anti-CD28 plus IL-2 and transduced with retroviral pMIG vectors expressing either GFP
alone (Empty) or GFP plus WT SLAT, DH, MyrDH, R236C, or Y133-144F mutants. Sorted GFP+ populations were restimulated with anti-CD3 and anti-CD28 for
2 hr. Cytoplasmic (C) and nuclear (N) fractions were immunoblotted with NFATc1 or -NFATc2 Abs. Fractions were also immunoblotted with anti-a-tubulin and
anti-lamin B to confirm purity of the fractions, respectively.
(B) Preactivated WT and SLAT-deficient (KO) primary CD4+ T cells were infected with the indicated retroviruses and differentiated under Th1 conditions. Cells
were harvested after three rounds of infection and rested for 24 hr, and GFP or GFP+ populations were sorted. IFN-g in culture supernatants was quantified
by ELISA 24 hr after anti-CD3+CD28 restimulation, and graphs show mean of IFN-g production ± SD. Statistical differences were determined using two-tailed
Student’s t test. #p < 0.001, WT versus SLAT-deficient mice.
(C) Preactivated SLAT-deficient OT-II CD4+ T cells were infected with empty pMIG retrovirus or with the indicated WT SLAT or SLAT mutant-expressing retro-
virus. As a control, WT OT-II T cells were transduced with empty pMIG retrovirus. Sorted GFP+ cells prepared after 7 days were adoptively transferred into naive
C57BL/6 mice, which were immunized 1 day later with Ova+CFA. Spleen cells harvested 6 days later were restimulated with Ova323–339 peptide, and IFN-g
+ cells
were enumerated. The background level of IFN-g-expressing GFP+ WT OT-II cells, which were not stimulated in vitro, was 2.5% (not shown).Immunity 29, 704–719, November 14, 2008 ª2008 Elsevier Inc. 717
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experiments.
Retroviral Transduction
The full-length SLAT cDNA in the pMIG retroviral vector was described (Ta-
naka et al., 2003). The pMIG-DH vector was generated as follows: First, the
SLAT DH domain (residues 313–630) was PCR-amplified with the forward
and reverse primers 50-AGATCTACCATGACTGATTTTTATCTGAAGCTGCAG
GCGGAGGGGAAGAC-30 and50-AGATCTCTAATTCCCTGGTGCTGGATCC-30,
respectively, then subcloned into the pGEM vector before being finally subcl-
oned into the BglII site of pMIG. Single mutants (pMIG-Y133-144F or D) were
generated by site-directed mutagenesis with the pMIG-SLAT vector as a tem-
plate. pMIG-MyrDH vector was obtained by first adding a HpaI site to pEF-
MyrDH vector via site-directed mutagenesis with the forward and reverse
primers 50-CAGTAGCTTGGTACCGTTAACATGGGCTGTGTCTGC-30 and 50-G
CAGACACAGCCCATGTTAACGGTACCAAGCTACTG-30, respectively, followed
by subcloning into the HpaI and EcoRI sites of pMIG. The retroviral vector of
Cdc42CA (pMX GFP Cdc42Q61L) was purchased from Addgene.
Platinum-E packaging cells (Morita et al., 2000) (0.43 106 cells) were plated
in a six-well plate in 2 ml DMEM plus 10% FBS. After overnight incubation, the
cells were transfected with 3 mg retroviral plasmid DNA with TransIT-LT1
transfection reagent. After 24 hr, the medium was replaced with RPMI plus
10% FBS. Cultures were maintained for 24 hr, and the retroviral supernatant
was harvested, filtered (0.45 mm), supplemented with 5 mg/ml polybrene and
100 U/ml IL-2, and then used to infect CD4+ T cells that had been preactivated
for 18 hr with CD3+CD28mAbs plus recombinant IL-2 (100 U/ml) under Th-1 or
Th2-polarizing conditions. Plates were centrifuged for 1 hr at 2000 rpm and
incubated for 8 hr at 32C and for 16 hr at 37C, followed by two additional
retroviral infections at daily intervals.
Adoptive Transfer and Ova Immunization
CD4+ T cells from OT-II WT or SLAT-deficient mice were isolated and cultured
with plate-bound anti-CD3 (5 mg/ml), soluble anti-CD28 (2.5 mg/ml), and IL-2
(100 U/ml). The cells were retrovirus-infected on days 2–4 and cultured for an-
other 3 days. GFP+ CD4+ T cells were sorted, and 2 3 105 cells were injected
intravenously into naive C57BL/6 mice. One day later, the mice were immu-
nized subcutaneously with Ova (50 mg; Grade V; Sigma-Aldrich) emulsified in
complete Freund’s adjuvant (CFA) (Difco; BD Diagnostics). Flow-cytometric
enumeration of transferred IFN-g+ T cells was performed 6 days later, after
in vitro restimulationwith OVA323–339 peptide (10 mg/ml) for 8 hr at 37
C in pres-
ence of Golgi Plug (BD Biosciences). Samples were analyzed on a FACSCali-
bur flow cytometer with CellQuest (BD Biosciences) and FlowJo software
(TreeStar) after gating on GFP+ and CD4+ T cells.
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